Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
16°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
Tickers
APTO
ATRA
AZN
BLU
Tags
CLSD
IBB
FATE
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBY
ASH21
From
Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
December 12, 2021
Tickers
ABBV
ALLO
ARGX
AZN
Tags
BMY
RHHBY
AZN
From
Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
December 10, 2021
Tickers
BMY
INFI
RHHBF
RHHBY
Tags
Benzinga
Biotech
Briefs
From
Benzinga
Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
December 10, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
RHHBF
RHHVF
General
From
Benzinga
7 Best Drug Stocks to Buy for 2022 Without Covid Catalysts
December 07, 2021
Tickers
BRK-A
BRK-B
HALO
LGVN
Tags
BRK/A
SESN
PFE
From
InvestorPlace
Europe Approves Roche's Tocilizumab For Patients With Severe COVID-19
December 07, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
RHHBY
Health Care
From
Benzinga
Immunocore' ImmTAC Candidate Shows Early Response In Ovarian And Head & Neck Cancer Patients
December 06, 2021
Tickers
IMCR
RHHBF
RHHBY
RHHVF
Tags
Solid Tumor
News
Phase 1 Trial
From
Benzinga
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
Tickers
ADAP
AGEN
ALPMY
GSK
Tags
XBI
ALPMY
GSK
From
Motley Fool
Biden's New COVID-19 Plan Includes Reimbursement For Over The Counter, At-Home COVID Tests
December 03, 2021
Tickers
ABT
BDX
CI
CVS
Tags
Diagnostics
RHHBY
Market News
From
Benzinga
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Tickers
ALPMF
ALPMY
NVS
RHHBF
Tags
News
Trading Ideas
Health Care
From
Benzinga
52 Biggest Movers From Yesterday
December 01, 2021
Tickers
ACET
AERC
AIH
ANNX
Tags
Industrials
MEIP
NUZE
From
Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
November 30, 2021
Tickers
ADAG
ADGI
AERC
ARRY
Tags
Mid/Day Movers
Penny Stocks
SNEX
From
Benzinga
ImmunoGen Shares Rally After Ovarian Cancer Trial Meets Primary Endpoint Goal
November 30, 2021
Tickers
IMGN
RHHBY
Tags
Small Cap
General
Movers
From
Benzinga
As FINRA's OTC Bulletin Board Closes Down, OTC Markets Group Becomes the Main Gateway Into the Regulated Over-the-Counter Market
November 30, 2021
Tickers
ADDYY
DANOY
OTCM
RHHBY
Tags
Market News
Markets
Partner Content
From
Benzinga
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
November 28, 2021
Tickers
BIIB
RHHBY
Tags
Recent Press Releases
Market News
BIIB
From
Motley Fool
Detecting Early Cancer Screening Stocks At An Early Stage Is Critical
November 22, 2021
Tickers
BMKDF
GH
MRNA
PFE
Tags
Market News
MRNA
Personal Finance
From
Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
Tickers
AMGN
AZN
BIIB
BMY
Tags
PFE
RHHBY
BMY
From
Motley Fool
Why Regeneron's Results for Its COVID Antibody Therapy Won't Boost Sales Much
November 20, 2021
Tickers
MRK
PFE
REGN
RHHBY
Tags
MRK
RHHBY
Market News
From
Motley Fool
Ocugen Stock: Bull vs. Bear
November 20, 2021
Tickers
BIIB
EDIT
JNJ
MRNA
Tags
NVAX
Market News
MRNA
From
Motley Fool
Roche's Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
November 19, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
European Medicines Agency
Phase 2 Trial
General
From
Benzinga
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
Health Care
NVO
NTLA
From
Benzinga
Spark Therapeutics' Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
November 18, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Phase 2 Trial
RHHBF
RHHVF
From
Benzinga
3 Biotech Stocks That Have More Than Tripled so far This Year
November 18, 2021
Tickers
BIIB
BNTX
LLY
OCGN
Tags
Market News
BNTX
OCGN
From
Motley Fool
Why Atea Pharmaceuticals Stock Is Sinking Today
November 17, 2021
Tickers
AVIR
MRK
PFE
RHHBY
Tags
Market News
RHHBY
MRK
From
Motley Fool
Atea Shares Plunge As Roche Culls Partnership To Develop COVID-19 Pill
November 17, 2021
Tickers
AVIR
RHHBF
RHHBY
RHHVF
Tags
Short Ideas
News
Health Care
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
November 17, 2021
Tickers
APWC
AVIR
CEI
CNSP
Tags
APWC
SPI
ENSC
From
InvestorPlace
Europe Approves Regeneron - Roche's COVID-19 Antibody Cocktail
November 12, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
RHHBF
FDA
RHHVF
From
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Tickers
ADPT
AFIB
ANVS
ATHX
Tags
OCUP
DRNA
ADPT
From
Benzinga
EU Regulator Backs Regeneron-Roche's COVID-19 Drug
November 11, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
COVID/19 Coronavirus
Health Care
News
From
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.